Bioreactor pump

The only bioreactor pump production base in the world is located in Qianyanghu, Hebei, which indicates that China has mastered the core technology of bioreactor pump development and production.

The bioreactor simulates the functions of organisms in vitro and utilizes the biological functions of enzymes or organisms to design reaction devices for the production or detection of various chemicals, such as fermentors, immobilized enzymes, or immobilized cell reactors. Wait. The human stomach is a complex bioreactor that processes food inside the human body. Food is digested by various enzymes in the stomach and becomes a nutrient that can be absorbed.

Bioreactors Scientists from all over the world have designed a variety of bioreactors for scientific research and production needs for high-density cultivation of animal, plant and microbial cells. Since animal cells (especially mammalian cells) are involved in erythropoietin (EPO, treatment of pernicious anaemia), interferon (IFN, treatment of viral diseases and tumors), prourokinase (Pro2UK, therapeutic thrombosis), vaccines and other values Due to the unique advantages in the production of expensive biological products, the development of bioreactors for animal cells has progressed rapidly in recent years and has broad prospects.

In 2007, Dr. Martin Evans, who won the Nobel Prize for medicine in 2007, and his research team were looking for partners around the world and eventually settled their production and research base in Qian'an, Hebei. The cell bioreactor produced by the park not only solved the technical problems of the seal of the valve and the asepsis, but also reduced the production cost of the instrument from US$200,000 to US$25,000, which greatly increased the marketization rate. (Original title: China masters bioreactor pump core technology)

On October 8, 2007, the Nobel Prize Committee of the Royal Swedish Academy of Sciences announced that the 2007 Nobel Prize in Physiology or Medicine was awarded to the British scientist Martin Evans for his contribution to stem cell research. Evans successfully separated similar "EC" cells from normal mouse embryos after returning to Cambridge in 1981 and Matt-Koffman. Evans' pioneering research created a new path for mammalian genes. He has been using gene knockouts and gene traps to conduct new discoveries and create animal models of human disease.